At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
clopidogrel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment (A Possible Mechanism of HOTPR:High On- Treatment Platelet Reactivity)
In Brief
An observational study evaluating clopidogrel and Placebos for Stable Angina. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The investigators designed the following experiment to observe the pattern of administration in vitro, which can be completely excluded liver enzyme cytochrome P450 metabolism under the influence and observe the relevant P2Y12 receptor downstream signal changes, hope in the above experiments, that the human body directly for the difference between the existence of drug reactions exist.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStable Angina
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJan 2017
First PostedJun 2017
Primary CompletionNov 2017
TodayJul 2026
First PostedJun 16, 2017
Enrollment StartJan 1, 2017
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.0 years ago
Interventions
clopidogreldrug
routine Dual antiplatelet therapy after stent implantation, then check PRU(platelet reactivity unit)
Placebosdrug
no medication, healthy subjects.